Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q3 FY25 results · Oct–Dec 2024
Amrutanjan Health Care reported revenue from operations of ₹122.75 crore (up 4.9% from Q3 FY24) and net profit of ₹19.25 crore (up 10.3% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a standalone basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 122.75 | 116.99 | +4.9% | 109.92 | +11.7% |
| Other income | 4.36 | 3.76 | +15.8% | 4.05 | +7.7% |
| Total income | 127.11 | 120.76 | +5.3% | 113.96 | +11.5% |
| Profit before tax | 25.99 | 23.71 | +9.6% | 15.94 | +63.0% |
| Net profit for the period | 19.25 | 17.45 | +10.3% | 11.80 | +63.2% |
| EPS, basic (₹) | 6.66 | 6.05 | +10.1% | 4.08 | +63.2% |
| Net margin (%) | 15.7 | 14.9 | 10.7 |
Standalone
- Filed with BSE
- 12 Feb 2025, 18:33 IST
- Board meeting
- 12 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE